Vermont Healthcare
Compliance Guide

Vermont presents a moderately friendly regulatory environment for healthcare companies, particularly those leveraging telehealth, though it maintains a strong commitment to patient safety and professional oversight. The state has historically been progressive in its adoption of telehealth, particularly accelerated by the COVID-19 pandemic, with many temporary flexibilities becoming permanent. Key regulatory bodies include the Vermont Board of Medical Practice, the Vermont Board of Nursing, and the Vermont Board of Pharmacy, all of which play crucial roles in licensing, professional conduct, and enforcement. The general business climate for healthcare operations emphasizes accessible, high-quality care, often through integrated systems. Vermont's regulatory framework, while generally supportive of innovation, is also characterized by a robust Corporate Practice of Medicine (CPOM) doctrine, which necessitates careful structuring for non-physician-owned entities. Recent legislative actions have primarily focused on solidifying telehealth parity, expanding access to care, and addressing workforce shortages. For instance, Act 129 (2022) made permanent many telehealth flexibilities, ensuring continued reimbursement parity and broad modality acceptance. The state also actively participates in interstate compacts to facilitate multi-state practice. Companies looking to operate in Vermont must navigate these regulations with precision, understanding that while the state encourages innovation, it does so within a framework designed to protect the integrity of the patient-provider relationship and the independence of clinical decision-making. Strategic planning around CPOM, professional licensing, and specific prescribing rules is paramount for successful and compliant operations.

Corporate Practice of Medicine (CPOM) in Vermont

Vermont maintains a robust Corporate Practice of Medicine (CPOM) doctrine, which generally prohibits corporations, entities, or individuals who are not licensed physicians from employing physicians or otherwise interfering with a physician's independent medical judgment. This doctrine is primarily rooted in common law and public policy, rather than a single overarching statute, though various professional licensing statutes reinforce its principles by defining who can practice medicine and under what conditions. The core intent of Vermont's CPOM doctrine is to protect the integrity of the physician-patient relationship, prevent commercial exploitation of medical services, and ensure that clinical decisions are made solely on the basis of patient care, free from lay interference.

Legal Basis and Enforcement

While Vermont does not have a specific 'CPOM statute' explicitly prohibiting the corporate practice of medicine, the Vermont Board of Medical Practice (VBMP) interprets its statutory authority to regulate the practice of medicine (e.g., 26 V.S.A. Chapter 23, §1311 et seq.) as implicitly upholding the CPOM doctrine. The VBMP is responsible for licensing physicians and enforcing professional standards, including those related to ethical practice and professional independence. Enforcement actions typically arise from complaints regarding unlicensed practice, fee-splitting, or undue influence over medical judgment by non-licensed entities.

Permitted Ownership Structures

Generally, only licensed physicians or professional corporations (PCs) owned and controlled by licensed physicians are permitted to practice medicine or employ physicians to provide medical services. Non-physicians are typically prohibited from having an ownership interest in entities that directly provide medical services. This restriction extends to various healthcare settings, including medspas, dental practices, and wellness clinics, where medical services are rendered. For example, a medspa offering medical aesthetic procedures must be owned and operated by a licensed physician or a physician-owned professional entity.

Non-Physician Ownership and Specific Restrictions

Non-physicians cannot own or control entities that directly provide medical care. This means that a standard C-corp or LLC owned by non-physicians cannot directly employ physicians or other licensed practitioners to deliver medical services. The restrictions aim to prevent:

• Fee-splitting: Arrangements where a non-licensed entity receives a percentage of a physician's professional fees for patient services, which is generally prohibited (26 V.S.A. §1354(a)(10)).
• Lay control over medical judgment: Situations where a non-licensed entity dictates or influences clinical decisions, treatment protocols, or billing practices.
• Unlicensed practice of medicine: When an entity or individual without a medical license effectively controls or directs the provision of medical services.

Impact on Telehealth Companies, Medspas, Dental Practices, and Wellness Clinics

• Telehealth Companies: Telehealth platforms operating in Vermont must carefully structure their relationships with physicians. Direct employment of physicians by a non-physician-owned telehealth company is generally impermissible. Instead, a Physician-Management Services Organization (P-MSO) model is commonly employed, where the non-physician entity provides administrative and technological services to a physician-owned professional entity, which then directly employs or contracts with the physicians.
• Medspas: Medspas offering medical procedures (e.g., injectables, laser treatments) must be physician-owned and operated. Non-physician ownership of the clinical entity is not allowed. The non-physician entity can only provide administrative and marketing support under a compliant MSO arrangement.
• Dental Practices: Similar to medical practices, dental practices must be owned by licensed dentists or dental professional corporations. Non-dentists cannot own or control dental practices.
• Wellness Clinics: If a wellness clinic offers services that constitute the practice of medicine (e.g., IV therapy, hormone therapy, GLP-1 prescriptions), it must adhere to CPOM requirements, meaning physician ownership and control of the clinical services component.

In all these cases, the P-MSO model is the most common compliant structure, where the non-physician entity provides non-clinical administrative and management services to a physician-owned professional entity under a Management Services Agreement (MSA). This MSA must be carefully drafted to avoid any perception of lay control over medical judgment or illegal fee-splitting.

Telehealth Laws in Vermont

Vermont has adopted a progressive stance on telehealth, particularly solidifying many pandemic-era flexibilities into permanent law. The state aims to ensure broad access to care through various telehealth modalities.

Establishment of Provider-Patient Relationship

Vermont law explicitly permits the establishment of a provider-patient relationship via telehealth, provided that the standard of care is met. This means an in-person visit is generally not required to initiate care. The Vermont Board of Medical Practice (VBMP) regulations and Act 129 (2022) affirm that a valid provider-patient relationship can be established through synchronous audio-visual technology, or in certain circumstances, through other appropriate modalities, as long as it allows for an adequate medical evaluation. The practitioner must ensure they have sufficient information to diagnose and treat the patient, which may involve reviewing medical records, conducting a thorough history, and, if necessary, referring for an in-person exam.

Permitted Modalities

Vermont's telehealth laws are inclusive regarding modalities:

• Synchronous Audio-Visual (Video): This is the preferred and most widely accepted modality for establishing new patient relationships and conducting follow-up care. It allows for visual assessment and real-time interaction.
• Synchronous Audio-Only (Telephone): Permitted for establishing new patient relationships and for follow-up care, especially when video is not available or appropriate, provided the standard of care can be met. Act 129 (2022) notably solidified audio-only as a reimbursable telehealth service.
• Asynchronous (Store-and-Forward): Allowed for certain types of care where the transmission of medical information (e.g., images, pre-recorded video, data) can be reviewed by a practitioner at a later time. This is often used for specialties like dermatology or ophthalmology. The practitioner must be able to render a diagnosis and treatment plan based solely on the transmitted information.
• Remote Patient Monitoring (RPM): Permitted and often reimbursed, allowing for the collection of health data from a patient in one location and electronic transmission to a provider in another location for review and intervention.

Telehealth Registration Requirements

Vermont does not have a separate 'telehealth registration' requirement for out-of-state providers beyond standard professional licensure. A practitioner must be fully licensed by the appropriate Vermont professional board (e.g., Vermont Board of Medical Practice, Vermont Board of Nursing) to provide telehealth services to patients located in Vermont. Participation in interstate compacts (e.g., Interstate Medical Licensure Compact (IMLC), Nurse Licensure Compact (NLC)) facilitates licensure for eligible practitioners.

Informed Consent Requirements

Specific informed consent for telehealth is generally required. While not always a separate, explicit form, the practitioner must ensure the patient understands:

• The nature of the telehealth services.
• Potential risks and benefits of telehealth, including privacy and security considerations.
• Alternatives to telehealth.
• The right to refuse telehealth services and receive in-person care.
• How to obtain follow-up care.
• Emergency protocols.

This consent can often be obtained verbally and documented in the patient's medical record, but written consent is often preferred for clarity and defensibility.

Geographic Restrictions

There are no specific geographic restrictions within Vermont regarding where a patient or provider must be located for telehealth services, beyond the general requirement that the patient must be located in Vermont at the time of the telehealth encounter. Providers must be licensed in Vermont, regardless of their physical location during the telehealth visit.

Controlled Substance Prescribing Rules for Telehealth in Vermont

Vermont adheres to federal and state regulations regarding the prescribing of controlled substances via telehealth, with particular attention to the establishment of a legitimate medical purpose and a valid patient-provider relationship. The federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances, with specific exceptions. The DEA's proposed rules, once finalized, will further define these exceptions.

Schedules Permitted via Telehealth

Currently, under the federal public health emergency (PHE) flexibilities that remain in effect, all schedules of controlled substances (Schedules II-V) can be prescribed via telehealth without a prior in-person examination, provided the prescribing practitioner acts in accordance with state law and maintains a legitimate medical purpose. Once the DEA finalizes its proposed rules, these flexibilities may be modified. It is critical to monitor DEA guidance. Vermont law largely aligns with federal requirements, emphasizing that any prescription, including for controlled substances, must be issued by a practitioner acting within the scope of their license and in the course of a legitimate professional relationship (26 V.S.A. §2092).

Specific DEA Requirements

• DEA Registration: Practitioners prescribing controlled substances to patients in Vermont must hold a valid DEA registration associated with their Vermont practice address. If prescribing from out-of-state, the DEA registration must be tied to a location where they are licensed to practice and where they maintain records.
• Legitimate Medical Purpose: All controlled substance prescriptions must be for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. This principle is paramount, regardless of the modality of care.
• Electronic Prescribing (EPCS): Vermont mandates electronic prescribing for all controlled substances (26 V.S.A. §2092(e)), with limited exceptions. This applies to telehealth prescribing as well.

PDMP Checking Requirements

Vermont has a robust Prescription Drug Monitoring Program (PDMP) administered by the Department of Health. Practitioners are generally required to check the PDMP before prescribing Schedule II, III, or IV controlled substances, and periodically thereafter, to assess for potential drug-seeking behavior or concurrent prescriptions (18 V.S.A. §4289). This requirement applies equally to telehealth encounters. Failure to check the PDMP can result in disciplinary action.

Quantity or Refill Limitations

Vermont law imposes specific quantity and refill limitations for certain controlled substances, particularly opioids. For acute pain, initial opioid prescriptions are often limited to a 7-day supply (18 V.S.A. §4205(c)). Refills are subject to medical necessity and ongoing assessment. These limitations apply to telehealth prescribing. Practitioners must also adhere to federal limits on refills for Schedule II substances (no refills) and Schedule III-V substances (up to 5 refills within 6 months).

Special Rules for Specific Drug Classes

• GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, GLP-1s require careful medical evaluation and monitoring. Prescribing via telehealth for weight loss or diabetes must adhere to the standard of care, including comprehensive patient assessment, appropriate diagnostics, and ongoing management. Off-label prescribing must be clinically justified and documented.
• Testosterone (Controlled Substance, Schedule III): Prescribing testosterone via telehealth requires a thorough diagnostic workup, including laboratory testing, to confirm hypogonadism. Ongoing monitoring and adherence to controlled substance prescribing guidelines are essential. The Ryan Haight Act exceptions (and future DEA rules) apply.
• Stimulants (Controlled Substance, Schedule II): Prescribing stimulants (e.g., Adderall, Ritalin) for ADHD via telehealth is particularly scrutinized. While currently permitted under PHE flexibilities, the DEA's proposed rules may require an in-person visit for the initial prescription of Schedule II stimulants. Even under current flexibilities, a comprehensive psychiatric evaluation, including a differential diagnosis, is critical. Long-term management requires regular follow-ups and PDMP checks. Practitioners must ensure they can adequately assess and monitor patients for potential abuse or diversion through telehealth modalities.

Scope of Practice for Mid-Level Providers in Vermont

Vermont is generally progressive regarding the scope of practice for mid-level providers, aiming to expand access to care, especially in rural areas. However, specific requirements for supervision and collaboration vary by profession.

Nurse Practitioners (NPs)

Vermont grants Full Practice Authority (FPA) to Nurse Practitioners (NPs). This means that after meeting specific educational and clinical experience requirements, a licensed NP can practice independently without physician supervision or a collaborative practice agreement.

• Requirements for FPA: To achieve FPA, a registered nurse must complete an accredited graduate-level education program, be certified by a national certifying body, and obtain licensure as an Advanced Practice Registered Nurse (APRN) from the Vermont Board of Nursing. Initially, new NPs may have a period of mentorship or consultation, but this is not a formal supervisory requirement.
• Scope: NPs with FPA can diagnose, treat, prescribe (including controlled substances), and manage patient care autonomously within their population focus (e.g., family, adult-gerontology, pediatrics). Their practice is defined by their education, training, and national certification, and is governed by the Vermont Board of Nursing (3 V.S.A. §124(a)(3), 26 V.S.A. Chapter 28).

Physician Assistants (PAs)

Physician Assistants (PAs) in Vermont practice under a supervisory relationship with a licensed physician. While PAs have a broad scope of practice, their activities must be delegated by and supervised by a physician.

• Supervision Requirements: The supervision does not necessarily require the physician to be physically present at all times but must be readily available for consultation. The scope of practice for a PA is determined by the supervising physician's scope of practice, the PA's education, experience, and competence, and the practice setting. A written practice agreement or delegation of services agreement between the PA and supervising physician is required, outlining the delegated medical tasks, methods of supervision, and emergency protocols (26 V.S.A. Chapter 31, §1731 et seq.).
• Prescribing Authority: PAs can prescribe medications, including controlled substances, within their scope of practice and under the supervision of their delegating physician, provided they have appropriate DEA registration.

Other Mid-Level Providers and Delegation Rules

• Certified Nurse-Midwives (CNMs) and Clinical Nurse Specialists (CNSs): These APRNs also generally have FPA in Vermont, similar to NPs, within their specialized scope of practice.
• Registered Nurses (RNs) and Licensed Practical Nurses (LPNs): Practice under the direction of a physician, NP, or PA, performing tasks within their licensed scope. They cannot independently diagnose or prescribe.
• Medical Assistants (MAs) in Medspas: MAs in Vermont operate under the direct supervision of a licensed physician, NP, or PA. Their scope is generally limited to administrative and clinical support tasks that do not require independent medical judgment. In medspas, MAs can perform delegated tasks like preparing patients, assisting with procedures, and providing post-procedure care, but they cannot perform procedures that constitute the practice of medicine (e.g., injections, laser treatments) unless specifically authorized and directly supervised by a licensed practitioner and within the MA's defined role. The delegating practitioner bears ultimate responsibility for the MA's actions.

Supervision Requirements Overview

• NPs: No formal physician supervision required after achieving FPA.
• PAs: Require a written practice agreement and ongoing supervision by a licensed physician.
• MAs: Require direct supervision by a licensed physician, NP, or PA for clinical tasks. The level of supervision (e.g., on-site, immediate availability) depends on the task and the delegating practitioner's judgment, but for invasive or high-risk procedures, direct, on-site supervision is often prudent or required.

Business Structuring Guidance for Healthcare Companies in Vermont

Navigating Vermont's Corporate Practice of Medicine (CPOM) doctrine is central to compliant business structuring. The P-MSO model is the predominant compliant structure for non-physician-owned healthcare businesses.

PC-MSO Structures: When Are They Needed?

Professional Corporation (PC) - Management Services Organization (MSO) structures are essential in Vermont when a non-physician individual or entity wishes to own or operate a business that facilitates or supports the delivery of medical services. This model is necessary for:

• Telehealth companies: If the platform is owned by non-physicians but employs or contracts with physicians to provide clinical services.
• Medspas, IV therapy clinics, wellness centers: If the owner is not a licensed physician but offers services that constitute the practice of medicine.
• Dental or chiropractic practices: If the owner is not a licensed dentist or chiropractor.

Under this model, the Professional Corporation (PC) (e.g., a Professional Medical Corporation, Professional Dental Corporation) is owned exclusively by licensed professionals (e.g., physicians, dentists). This PC directly employs or contracts with the licensed practitioners who provide the clinical services. The PC holds the necessary professional licenses and registrations (e.g., medical license, DEA registration).

The Management Services Organization (MSO) is a separate entity, which can be owned by non-physicians. The MSO enters into a Management Services Agreement (MSA) with the PC. Under this MSA, the MSO provides all non-clinical administrative, technical, and business support services to the PC. These services typically include billing, scheduling, marketing, IT support, facility management, equipment leasing, and non-clinical staff management.

Fee-Splitting Rules

Vermont has strict prohibitions against fee-splitting. Vermont law (e.g., 26 V.S.A. §1354(a)(10) for physicians) prohibits licensed professionals from sharing fees with or paying commissions to any person for referring patients. This means:

• The MSO cannot receive a percentage of the professional fees generated by the PC for patient services.
• The MSO's compensation from the PC must be for fair market value (FMV) for the actual administrative and management services provided. This compensation should typically be a fixed fee, a cost-plus arrangement, or a percentage of the PC's net profits (after physician compensation and operating expenses), but never a percentage of gross revenue or professional fees directly attributable to patient services. The compensation must be independent of the volume or value of referrals or patient services.
• Any arrangement that incentivizes referrals or dictates clinical decisions based on financial gain for the MSO is highly scrutinized and likely prohibited.

Management Services Agreement (MSA) Requirements

A compliant MSA is the cornerstone of a P-MSO structure. Key requirements include:

• Clear Delineation of Services: The MSA must explicitly list the administrative and non-clinical services the MSO provides to the PC.
• Fair Market Value Compensation: The MSO's compensation must be commercially reasonable and at FMV for the services rendered, documented by independent valuation if feasible.
• No Clinical Control: The MSA must unequivocally state that the PC and its licensed professionals retain sole control over all clinical decisions, patient care, hiring/firing of clinical staff, and professional standards. The MSO cannot interfere with medical judgment.
• Term and Termination: Standard contract provisions for term, termination, and dispute resolution.
• Compliance with Law: Explicit clauses affirming compliance with all applicable federal and state laws, including CPOM and anti-kickback statutes.

Professional Corporation Requirements

Vermont law (e.g., 11A V.S.A. Chapter 4, Professional Corporations) dictates specific requirements for professional corporations:

• Ownership: All shareholders of a professional corporation must be licensed in the profession for which the corporation is organized (e.g., all shareholders of a medical PC must be licensed physicians).
• Corporate Name: The corporate name must include words like 'Professional Corporation' or 'P.C.' and indicate the profession.
• Purpose: The PC's sole purpose must be to render the specific professional services for which its shareholders are licensed.
• Licensure: The PC itself may need to register with the relevant professional board, in addition to individual practitioner licensure.

How to Structure Ownership for Compliance

1. Identify Clinical Services: Determine which services offered constitute the 'practice of medicine' (or dentistry, etc.) under Vermont law.
2. Establish Professional Entity: Form a Vermont Professional Corporation (PC) owned 100% by licensed professionals (e.g., physicians) for the purpose of delivering these clinical services.
3. Form MSO: Create a separate business entity (e.g., LLC, C-Corp) for the non-clinical management and administrative functions. This MSO can be owned by non-physicians.
4. Draft MSA: Execute a comprehensive MSA between the PC and the MSO, ensuring FMV compensation for MSO services and strict separation of clinical and administrative control.
5. Licensing: Ensure all individual practitioners are properly licensed in Vermont. The PC itself may also require registration with the Board of Medical Practice.
6. Compliance Audit: Regularly review the structure and agreements to ensure ongoing compliance with CPOM, fee-splitting, and other regulatory requirements. This includes ensuring that the MSO does not exert de facto control over clinical operations, even if the MSA states otherwise.

Recent Regulatory Changes and Pending Legislation in Vermont (2024-2026)

Vermont continues to be an active legislative and regulatory environment, particularly concerning healthcare access and innovation. Key developments and trends include:

Telehealth Legislation and Board Actions

• Permanent Telehealth Flexibilities (Act 129, 2022): While passed in 2022, the full impact of Act 129 continues to shape Vermont's telehealth landscape. It made permanent many of the pandemic-era telehealth flexibilities, including reimbursement parity for audio-only and audio-visual telehealth services, and clarified that a provider-patient relationship can be established via telehealth. This legislation underpins the stability of telehealth operations in the state for 2024-2026.
• Rulemaking by Professional Boards: The Vermont Board of Medical Practice and Board of Nursing are continually updating their administrative rules to align with Act 129 and address emerging telehealth practice issues. Companies should monitor proposed rule changes on the Vermont Secretary of State's website, particularly concerning informed consent, documentation, and specific practice standards for telehealth.

Corporate Practice of Medicine (CPOM) and Business Structuring

• No Major Legislative Changes to CPOM: As of early 2025, there have been no significant legislative actions to fundamentally alter Vermont's common law CPOM doctrine. The P-MSO model remains the primary compliant structure for non-physician-owned healthcare entities. Enforcement remains primarily through the professional boards and their interpretation of professional conduct standards.
• Increased Scrutiny of Management Agreements: With the proliferation of telehealth and medspa models, regulatory bodies are increasing their scrutiny of Management Services Agreements (MSAs) to ensure they genuinely separate clinical and administrative functions and do not facilitate illegal fee-splitting or lay control over medical judgment. This trend is expected to continue.

Prescribing Rules and Controlled Substances

• Federal DEA Telehealth Prescribing Rules: The most significant pending development affecting Vermont's telehealth prescribing of controlled substances is the finalization of the DEA's proposed rules regarding the Ryan Haight Act. These rules, expected to be finalized in 2024 or 2025, will determine the long-term requirements for prescribing controlled substances via telehealth, potentially reintroducing an in-person visit requirement for initial prescriptions of certain Schedule II substances. Vermont practitioners must adhere to federal rules in addition to state law.
• PDMP Enhancements: Vermont continues to invest in its Prescription Drug Monitoring Program (PDMP). Expect ongoing efforts to integrate PDMP data with electronic health records (EHRs) and potentially expand mandatory checking requirements or enhance data analytics to combat the opioid crisis and other controlled substance misuse.

Interstate Compact Participation Updates

• Interstate Medical Licensure Compact (IMLC): Vermont is an active member of the IMLC (3 V.S.A. Chapter 61), facilitating expedited licensure for eligible physicians. This continues to be a stable mechanism for multi-state practice.
• Nurse Licensure Compact (NLC): Vermont is also a member of the NLC (3 V.S.A. Chapter 62), allowing nurses holding a compact license in their home state to practice in Vermont without obtaining additional Vermont licensure.
• Other Compacts: Monitor for Vermont's potential participation in other emerging interstate compacts for professions like physical therapy or psychology, which could further streamline multi-state operations.

Workforce Development and Access to Care

• Loan Forgiveness and Incentives: Vermont frequently introduces legislation aimed at addressing healthcare workforce shortages, particularly in rural and underserved areas. This includes loan forgiveness programs and incentives for practitioners to practice in specific regions or specialties.
• Scope of Practice Expansion: While NPs already have FPA, there may be ongoing discussions or legislative proposals to further optimize the scope of practice for other allied health professionals to enhance access to care.

Practical Guidance for Healthcare Companies Entering Vermont

Navigating Vermont's regulatory landscape requires a proactive and precise approach. Here's actionable guidance:

Step-by-Step Compliance Checklist

1. Entity Formation & CPOM Compliance:
   • Determine Service Type: Clearly identify if your services constitute the 'practice of medicine' (or other licensed profession) in Vermont.
   • Structure Appropriately: If medical services are involved and non-physicians own the core business, establish a Vermont Professional Corporation (PC) owned by licensed physicians. Form a separate Management Services Organization (MSO) for non-clinical functions.
   • Draft MSA: Execute a robust Management Services Agreement (MSA) between the PC and MSO, ensuring FMV compensation and strict separation of clinical control.
2. Professional Licensing:
   • Individual Licensure: Ensure all practitioners (physicians, NPs, PAs, etc.) providing services to Vermont patients are individually licensed by the respective Vermont professional board (e.g., VT Board of Medical Practice, VT Board of Nursing).
   • Compact Utilization: Leverage the IMLC or NLC if applicable to expedite physician and nurse licensure.
   • DEA Registration: All prescribers of controlled substances must have a valid Vermont-specific DEA registration.
3. Telehealth Protocols:
   • Informed Consent: Implement clear, documented informed consent processes for all telehealth patients, covering risks, benefits, and emergency procedures.
   • Modality Adherence: Ensure your platform supports synchronous audio-visual for initial patient encounters and that other modalities are used appropriately and meet the standard of care.
   • Documentation: Maintain comprehensive medical records for all telehealth encounters, equivalent to in-person visits.
4. Prescribing Compliance:
   • PDMP Checks: Integrate mandatory PDMP checks into prescribing workflows for controlled substances. Document all checks.
   • EPCS: Ensure your prescribing system is capable of Electronic Prescribing of Controlled Substances (EPCS) and that all prescribers are enrolled.
   • Federal DEA Rules: Closely monitor and adapt to the finalization of the DEA's telehealth prescribing rules, especially for Schedule II substances.
5. Scope of Practice:
   • NP FPA: Understand that NPs have full practice authority. Ensure your protocols reflect this autonomy.
   • PA Supervision: For PAs, ensure a current, written practice agreement with a supervising physician is in place and that supervision requirements are met.
   • MA Delegation: Clearly define the scope of practice for Medical Assistants, especially in medspas, ensuring direct supervision for all clinical tasks and adherence to delegation rules.

Common Pitfalls to Avoid

• Ignoring CPOM: Assuming a standard LLC or corporate structure is permissible for medical services. This is a primary compliance risk in Vermont.
• Improper MSO Compensation: Structuring MSO fees as a percentage of gross professional revenue, which can be deemed illegal fee-splitting.
• Lack of Vermont Licensure: Providing services to Vermont patients without proper individual professional licensure.
• Inadequate Telehealth Consent: Failing to obtain and document appropriate informed consent for telehealth services.
• Non-Compliance with PDMP: Skipping mandatory PDMP checks for controlled substance prescribing.
• Lay Control: Allowing non-clinical management to influence clinical decisions or professional judgment.

Timeline Expectations for Licensing and Setup

• Individual Professional Licensure: Varies by board. Physician licensure can take 2-4 months (or less with IMLC). NP/PA licensure typically 1-3 months. Plan accordingly.
• DEA Registration: After state licensure, DEA registration can take 2-4 weeks.
• Entity Formation (PC/MSO): A few weeks for corporate filings with the Vermont Secretary of State.
• MSA Negotiation/Drafting: Can take several weeks to months, depending on complexity and legal review.
• Credentialing & Payer Enrollment: This is often the longest lead time, ranging from 3-6 months or more for commercial and state payers (e.g., Vermont Medicaid). Start this process as early as possible.

Overall: Budget at least 4-6 months for full operational readiness, assuming all legal and administrative steps are initiated promptly.